Comparative Study of the Performance of Drug Anamneses in an Emergency Department
NCT ID: NCT05951881
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2023-02-15
2023-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After checking with the patient's reference pharmacy, the pharmacist and pharmacy assistant compare their results.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emergency Pharmacist Safety Study
NCT00382434
The Effect of Medication Review in High-risk Emergency Department Patients
NCT02122965
the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
NCT01906710
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction
NCT03621111
The Pharmacist in the Acute Geriatric Inpatient Treatment Team
NCT03412903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Urgent care unit patients with medication
All patients admitted to the emergency department who agree to describe their medication
Emergency Care Unit - medicines
The same group of patients admitted to the emergency room will respond separately to a pharmacist and a pharmacy assistant about their daily medication.
The two medical records will be compared in order to evaluate the work of the pharmacy assistant on the basis of 3 sources :
* the Electronic Medical Record
* the patient's medication history
* the reference pharmacy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emergency Care Unit - medicines
The same group of patients admitted to the emergency room will respond separately to a pharmacist and a pharmacy assistant about their daily medication.
The two medical records will be compared in order to evaluate the work of the pharmacy assistant on the basis of 3 sources :
* the Electronic Medical Record
* the patient's medication history
* the reference pharmacy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years old
* Giving consent to participate
Exclusion Criteria
* Unconscious patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grand Hôpital de Charleroi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurence Rosart, Pharmacist
Role: PRINCIPAL_INVESTIGATOR
Grand Hôpital de Charleroi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GHdC
Charleroi, Hainaut, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pharmacie - Protocole V4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.